Abstract
Green tea is now known to be the most effective beverage for cancer prevention, and evidence of this was recently extended to clinical applications. This paper briefly reviews several topics with regard to the development of our study on cancer prevention with green tea, and proposes a strategy for two-stages of cancer prevention with green tea. The topics are : 1) introduction of our initial work on (-)-epigallocatechin gallate (EGCG), the main constituent of Japanese green tea; 2) cancer preventive effects of EGCG and green tea extract, the lyophilized form of green tea infusion; 3) bioavailability of 3H-EGCG in mice; 4) delay of cancer onset by drinking 10 Japanese-size cups of green tea per day; 5) a prototype study for developing green tea beverage supplemented with green tea tablets by 102 healthy volunteers; 6) cancer prevention before cancer onset for the general population and high risk groups; 7) cancer prevention for patients following cancer treatment; 8) an example of a clinical trial looking toward prevention of cancer recurrence in the liver; and 9) possible prevention of human lung cancer. Considering all the above, green tea is a multi-, non-toxic cancer preventive for humans: It is natures remedy.
Keywords: green tea, egcg, 10 japanese-size cups, general population, cancer patients
Current Cancer Therapy Reviews
Title: Cancer Prevention with Green Tea Polyphenols for the General Population, and for Patients Following Cancer Treatment
Volume: 1 Issue: 1
Author(s): Hirota Fujiki, Masami Suganuma, Satoru Matsuyama and Kohji Miyazaki
Affiliation:
Keywords: green tea, egcg, 10 japanese-size cups, general population, cancer patients
Abstract: Green tea is now known to be the most effective beverage for cancer prevention, and evidence of this was recently extended to clinical applications. This paper briefly reviews several topics with regard to the development of our study on cancer prevention with green tea, and proposes a strategy for two-stages of cancer prevention with green tea. The topics are : 1) introduction of our initial work on (-)-epigallocatechin gallate (EGCG), the main constituent of Japanese green tea; 2) cancer preventive effects of EGCG and green tea extract, the lyophilized form of green tea infusion; 3) bioavailability of 3H-EGCG in mice; 4) delay of cancer onset by drinking 10 Japanese-size cups of green tea per day; 5) a prototype study for developing green tea beverage supplemented with green tea tablets by 102 healthy volunteers; 6) cancer prevention before cancer onset for the general population and high risk groups; 7) cancer prevention for patients following cancer treatment; 8) an example of a clinical trial looking toward prevention of cancer recurrence in the liver; and 9) possible prevention of human lung cancer. Considering all the above, green tea is a multi-, non-toxic cancer preventive for humans: It is natures remedy.
Export Options
About this article
Cite this article as:
Fujiki Hirota, Suganuma Masami, Matsuyama Satoru and Miyazaki Kohji, Cancer Prevention with Green Tea Polyphenols for the General Population, and for Patients Following Cancer Treatment, Current Cancer Therapy Reviews 2005; 1 (1) . https://dx.doi.org/10.2174/1573394052952474
DOI https://dx.doi.org/10.2174/1573394052952474 |
Print ISSN 1573-3947 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6301 |
![](/images/wayfinder.jpg)
- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Biologically Active Natural Products of the Genus Callicarpa
Current Bioactive Compounds Bortezomib as the First Proteasome Inhibitor Anticancer Drug: Current Status and Future Perspectives
Current Cancer Drug Targets Antineovascular Agents in the Treatment of Eye Diseases
Current Pharmaceutical Design Vybrant DyeCycle Violet Stain Discriminates Two Different Subsets of CD34+ Cells
Current Stem Cell Research & Therapy Multicolor-FISH Approaches for the Characterization of Human Chromosomes in Clinical Genetics and Tumor Cytogenetics
Current Genomics Curcumin Targets in Inflammation and Cancer
Endocrine, Metabolic & Immune Disorders - Drug Targets Promiscuous Biological Features of Newly Emerged SARS-CoV-2 Facilitate its Unrestrained Outbreak: An Update
Coronaviruses Oxidative Stress, Pro-Inflammatory Cytokines, and Antioxidants Regulate Expression Levels of MicroRNAs in Parkinson’s Disease
Current Aging Science Mevalonate Kinase Deficiency: Disclosing the Role of Mevalonate Pathway Modulation in Inflammation
Current Pharmaceutical Design Medicinal Chemistry Perspective of Fused Isoxazole Derivatives
Current Topics in Medicinal Chemistry Novel Insight into Differential Gene Expression and Clinical Significance of Dopamine Receptors, COMT, and IL6 in BPH and Prostate Cancer
Current Molecular Medicine Cancer Biomarker Discovery for Precision Medicine: New Progress
Current Medicinal Chemistry Pharmacology of Rhein and Advancement in the Synthesis of Its Derivatives
Current Traditional Medicine Suicide Gene Therapy Mediated by the Herpes Simplex Virus Thymidine Kinase Gene / Ganciclovir System: Fifteen Years of Application
Current Gene Therapy Formulation, Optimization and <i>In vitro / In vivo</i> Characterization of Spray Dried Doxorubicin Loaded Folic Acid Conjugated Gelatin Nanoparticles
Current Molecular Pharmacology Hypoxia Responsive Drug Delivery Systems in Tumor Therapy
Current Pharmaceutical Design Design, Synthesis and Biological Evaluation of 4, 6-Coumarin Derivatives as Anti- Cancer and Apoptosis-Inducing Agents
Anti-Cancer Agents in Medicinal Chemistry Preclinical and Clinical Efficacy of the Bisphosphonate Ibandronate in Cancer Treatment
Current Clinical Pharmacology Targeting p53 in Cancer
Current Medicinal Chemistry - Anti-Cancer Agents FoxO Transcription Factors and Regenerative Pathways in Diabetes Mellitus
Current Neurovascular Research